Literature DB >> 19683269

Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol.

Jean J M C H de la Rosette1, Margot H Wink, Charalampos Mamoulakis, Niels Wondergem, Fiebo J C ten Kate, Koos Zwinderman, Theo M de Reijke, Hessel Wijkstra.   

Abstract

PURPOSE: We compared prostate cancer detection rates achieved using an 8 and 12-core biopsy protocol in a clinical population to determine the significance of additional transition zone sampling on repeat biopsy.
MATERIALS AND METHODS: Between September 2004 and September 2007, 269 eligible patients with a clinical suspicion of prostate cancer referred to our department were randomized to an 8-core lateral (group 1) or a 12-core lateral and parasagittal (group 2) transrectal ultrasound guided prostate biopsy protocol. Study inclusion criteria were age dependent increased serum prostate specific antigen (1.25 ng/ml or greater at ages less than 50 years, 1.75 or greater at ages 50 to less than 60 years, 2.25 or greater at ages 60 to less than 70 years and 3.25 or greater at ages 70 years or greater), positive digital rectal examination and/or suspicious transrectal ultrasound. After negative first round biopsy patients underwent 12-core biopsy, including 4 transition zone cores.
RESULTS: Nine patients were excluded from analysis because of protocol violation or they did not complete the whole biopsy procedure due to discomfort. The cancer detection rate in groups 1 and 2 did not differ significantly (34.1% or 45 of 132 patients and 38.3% or 49 of 128, respectively, p = 0.48). Detected cancer median Gleason scores were similar in the groups. Of 109 patients who underwent repeat biopsy prostate cancer was detected in 20 (14.4%), of whom 9 had positive cores from the transition zone and 6 had positive biopsies only from the transition zone.
CONCLUSIONS: There are no statistically significant differences in the prostate cancer detection rate between 8 and 12-core prostate biopsy protocols. Transition zone biopsies contribute to prostate cancer detection in a repeat biopsy protocol.

Entities:  

Mesh:

Year:  2009        PMID: 19683269     DOI: 10.1016/j.juro.2009.06.037

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  [MRI navigated stereotactic prostate biopsy: fusion of MRI and real-time transrectal ultrasound images for perineal prostate biopsies].

Authors:  T H Kuru; C Tulea; T Simpfendörfer; V Popeneciu; M Roethke; B A Hadaschik; M Hohenfellner
Journal:  Urologe A       Date:  2012-01       Impact factor: 0.639

2.  Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.

Authors:  D M Somford; W Vreuls; T S Jansen; J P van Basten; H Vergunst
Journal:  World J Urol       Date:  2013-07-20       Impact factor: 4.226

3.  18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer.

Authors:  Olayinka A Abiodun-Ojo; Akinyemi A Akintayo; Oladunni O Akin-Akintayo; Funmilayo I Tade; Peter T Nieh; Viraj A Master; Mehrdad Alemozaffar; Adeboye O Osunkoya; Mark M Goodman; Baowei Fei; David M Schuster
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

4.  Risk factors for acute prostatitis after transrectal biopsy of the prostate.

Authors:  Sang Jin Kim; Sun Il Kim; Hyun Soo Ahn; Jong Bo Choi; Young Soo Kim; Se Joong Kim
Journal:  Korean J Urol       Date:  2010-06-21

5.  Molecular imaging and fusion targeted biopsy of the prostate.

Authors:  Baowei Fei; Peter T Nieh; Viraj A Master; Yun Zhang; Adeboye O Osunkoya; David M Schuster
Journal:  Clin Transl Imaging       Date:  2016-12-01

6.  Optimal biopsy strategy for prostate cancer detection by performing a Bayesian network meta-analysis of randomized controlled trials.

Authors:  Yi Wang; Jundong Zhu; Zhiqiang Qin; Yamin Wang; Chen Chen; Yichun Wang; Xiang Zhou; Qijie Zhang; Xianghu Meng; Ninghong Song
Journal:  J Cancer       Date:  2018-06-05       Impact factor: 4.207

7.  Comparison of diagnostic efficacy between transrectal and transperineal prostate biopsy: A propensity score-matched study.

Authors:  Chen-Yi Jiang; Peng-Fei Shen; Cheng Wang; Hao-Jun Gui; Yuan Ruan; Hao Zeng; Shu-Jie Xia; Qiang Wei; Fu-Jun Zhao
Journal:  Asian J Androl       Date:  2019 Nov-Dec       Impact factor: 3.285

8.  Transperineal ultrasound-guided 12-core prostate biopsy: an extended approach to diagnose transition zone prostate tumors.

Authors:  Ming-Hua Yao; Li-Ling Zou; Rong Wu; Le-Hang Guo; Guang Xu; Juan Xie; Pei Li; Shuai Wang
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.